NASDAQ:CSII Cardiovascular Systems (CSII) Stock Forecast, Price & News $20.00 0.00 (0.00%) (As of 05/11/2023) Add Compare Share Share Today's Range$20.00▼$20.0050-Day Range$19.74▼$20.0052-Week Range$12.26▼$20.57Volume4,300 shsAverage Volume765,906 shsMarket Capitalization$843.96 millionP/E RatioN/ADividend YieldN/APrice Target$20.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Cardiovascular Systems MarketRank™ ForecastAnalyst RatingHold1.50 Rating ScoreUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainability-1.05Upright™ Environmental ScoreNews Sentiment-0.24Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.68) to ($0.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.21 out of 5 starsMedical Sector983rd out of 1,006 stocksSurgical & Medical Instruments Industry104th out of 104 stocks 0.8 Analyst's Opinion Consensus RatingCardiovascular Systems has received a consensus rating of Hold. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageCardiovascular Systems has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for CSII. Previous Next 0.0 Dividend Strength Dividend YieldCardiovascular Systems does not currently pay a dividend.Dividend GrowthCardiovascular Systems does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCardiovascular Systems has received a 61.33% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Clinical research services for physiological diseases ", "Coronary stents", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for Cardiovascular Systems is -1.05. Previous Next 1.5 News and Social Media Coverage News SentimentCardiovascular Systems has a news sentiment score of -0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cardiovascular Systems this week, compared to 1 article on an average week.Search Interest1 people have searched for CSII on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Cardiovascular Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardiovascular Systems insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.80% of the stock of Cardiovascular Systems is held by insiders.Percentage Held by Institutions86.61% of the stock of Cardiovascular Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cardiovascular Systems are expected to grow in the coming year, from ($0.68) to ($0.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardiovascular Systems is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardiovascular Systems is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardiovascular Systems has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cardiovascular Systems (NASDAQ:CSII) StockCardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.Read More Receive CSII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address CSII Stock News HeadlinesMay 30, 2023 | omaha.comAHA News: Higher Cardiovascular Risk Score Linked to Lower Cognitive FunctionMay 30, 2023 | americanbankingnews.comCardiovascular Systems (NASDAQ:CSII) Coverage Initiated by Analysts at StockNews.comMay 31, 2023 | Edge On The Street (Ad)146 Pounds of Graphite Needed for Each EVGraphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.May 23, 2023 | americanbankingnews.comCardiovascular Systems (NASDAQ:CSII) Now Covered by StockNews.comMay 15, 2023 | yahoo.comWhat Is Cardiovascular Disease — Exactly? This Definition and Warning Signs Could Save Your LifeMay 14, 2023 | americanbankingnews.comCardiovascular Systems (NASDAQ:CSII) Now Covered by Analysts at StockNews.comMay 6, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Cardiovascular Systems (NASDAQ:CSII)April 28, 2023 | americanbankingnews.comCardiovascular Systems (NASDAQ:CSII) Receives New Coverage from Analysts at StockNews.comMay 31, 2023 | Edge On The Street (Ad)146 Pounds of Graphite Needed for Each EVGraphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.April 27, 2023 | markets.businessinsider.comAbbott Completes Acquisition of Cardiovascular Systems, Inc.April 27, 2023 | startribune.comAbbott closes on $890 million acquisition of New Brighton's Cardiovascular SystemsApril 26, 2023 | seekingalpha.comCSII Cardiovascular Systems, Inc.April 21, 2023 | benzinga.comCardiovascular Systems Stock (NASDAQ:CSII), DividendsApril 21, 2023 | americanbankingnews.comCardiovascular Systems (NASDAQ:CSII) Coverage Initiated at StockNews.comApril 20, 2023 | msn.comRecent Filing Shows That Sen. Tina Smith Sold Over $100K Worth of Cardiovascular Systems StockApril 19, 2023 | finance.yahoo.comCardiovascular Systems, Inc.'s (NASDAQ:CSII) Subdued P/S Might Signal An OpportunityApril 6, 2023 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, OSH, MAXRApril 3, 2023 | finance.yahoo.comCardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical TrialMarch 30, 2023 | americanbankingnews.comCardiovascular Systems, Inc. (NASDAQ:CSII) Short Interest UpdateMarch 25, 2023 | marketwatch.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, CSII, MPB, TIGMarch 24, 2023 | finance.yahoo.comWhy Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?March 23, 2023 | finance.yahoo.comWhy Is Medtronic (MDT) Down 6.1% Since Last Earnings Report?March 21, 2023 | americanbankingnews.comCardiovascular Systems (NASDAQ:CSII) Earns Hold Rating from Analysts at StockNews.comMarch 20, 2023 | finance.yahoo.comCardiovascular Systems (CSII) Ails From Soft Volume, Macro WoesMarch 1, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn SituationFebruary 14, 2023 | benzinga.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Cardiovascular Systems, Inc. - CSIIFebruary 13, 2023 | prnewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Cardiovascular Systems, Inc. - CSIISee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CSII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address CSII Company Calendar Last Earnings2/08/2023Today5/31/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:CSII CUSIP14161910 CIK1180145 Webwww.csi360.com Phone(651) 259-1600Fax612-677-3355Employees780Year Founded1989Price Target and Rating Average Stock Price Forecast$20.00 High Stock Price Forecast$25.00 Low Stock Price Forecast$15.00 Forecasted Upside/Downside0.0%Consensus RatingHold Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,930,000.00 Net Margins-15.79% Pretax Margin-15.73% Return on Equity-15.39% Return on Assets-11.93% Debt Debt-to-Equity Ratio0.08 Current Ratio6.04 Quick Ratio4.92 Sales & Book Value Annual Sales$239.84 million Price / Sales3.52 Cash FlowN/A Price / Cash FlowN/A Book Value$6.12 per share Price / Book3.27Miscellaneous Outstanding Shares42,198,000Free Float40,594,000Market Cap$843.96 million OptionableOptionable Beta0.74 Social Links Key ExecutivesScott R. WardChairman, President & Chief Executive OfficerJohn M. HastingsExecutive Vice President-Operations & TechnologyJeffrey S. PointsChief Financial OfficerJeffery W. ChambersChief Medical OfficerAndrew P. O'BrienVice President-Information TechnologyKey CompetitorsOrthofix MedicalNASDAQ:OFIXAngioDynamicsNASDAQ:ANGOAccurayNASDAQ:ARAYSurmodicsNASDAQ:SRDXAlphatecNASDAQ:ATECView All CompetitorsInstitutional OwnershipWater Island Capital LLCBought 1,598,931 shares on 5/25/2023Ownership: 3.789%Ameriprise Financial Inc.Bought 69,676 shares on 5/22/2023Ownership: 0.691%JPMorgan Chase & Co.Bought 16,100 shares on 5/18/2023Ownership: 0.815%Thrivent Financial for LutheransSold 6,004 shares on 5/17/2023Ownership: 0.099%Squarepoint Ops LLCBought 16,911 shares on 5/16/2023Ownership: 0.130%View All Institutional Transactions CSII Stock - Frequently Asked Questions Should I buy or sell Cardiovascular Systems stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CSII shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSII, but not buy additional shares or sell existing shares. View CSII analyst ratings or view top-rated stocks. What is Cardiovascular Systems' stock price forecast for 2023? 2 analysts have issued 1 year price targets for Cardiovascular Systems' shares. Their CSII share price forecasts range from $15.00 to $25.00. On average, they expect the company's share price to reach $20.00 in the next year. View analysts price targets for CSII or view top-rated stocks among Wall Street analysts. How have CSII shares performed in 2023? Cardiovascular Systems' stock was trading at $13.62 on January 1st, 2023. Since then, CSII stock has increased by 46.8% and is now trading at $20.00. View the best growth stocks for 2023 here. How were Cardiovascular Systems' earnings last quarter? Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings data on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to the consensus estimate of $63.06 million. Cardiovascular Systems had a negative net margin of 15.79% and a negative trailing twelve-month return on equity of 15.39%. Cardiovascular Systems's quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.23) earnings per share. What ETFs hold Cardiovascular Systems' stock? ETFs with the largest weight of Cardiovascular Systems (NASDAQ:CSII) stock in their portfolio include AltShares Merger Arbitrage ETF (ARB), IQ Merger Arbitrage ETF (MNA), AltShares Event-Driven ET (EVNT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Invesco Nasdaq Future Gen 200 ETF (QQQS), Principal Healthcare Innovators ETF (BTEC) and iShares Micro-Cap ETF (IWC). What is Scott Ward's approval rating as Cardiovascular Systems' CEO? 35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend. What other stocks do shareholders of Cardiovascular Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG). What is Cardiovascular Systems' stock symbol? Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII." Who are Cardiovascular Systems' major shareholders? Cardiovascular Systems' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (17.01%), Brown Capital Management LLC (6.73%), Champlain Investment Partners LLC (5.45%), State Street Corp (3.96%), Water Island Capital LLC (3.79%) and Gabelli Funds LLC (2.08%). Insiders that own company stock include Alexander Rosenstein, Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward. View institutional ownership trends. How do I buy shares of Cardiovascular Systems? Shares of CSII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cardiovascular Systems' stock price today? One share of CSII stock can currently be purchased for approximately $20.00. How much money does Cardiovascular Systems make? Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $843.96 million and generates $239.84 million in revenue each year. The medical device company earns $-36,930,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis. How many employees does Cardiovascular Systems have? The company employs 780 workers across the globe. How can I contact Cardiovascular Systems? Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for the company is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355. This page (NASDAQ:CSII) was last updated on 5/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiovascular Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.